OP Asset Management Ltd

Source: SEC Form 13F · as of Mar 2026

OP Asset Management Ltd holds 64 biotech & pharma companies tracked by BioSniper, totaling $1.54B in value as of Mar 2026 (SEC Form 13F).

Companies held

64

Total value held

$1.54B

CompanySharesValue
LLYELI LILLY & Co333,226$330.4M
JNJJOHNSON & JOHNSON900,718$237.4M
ABBVAbbVie Inc.621,804$145.8M
UNHUnitedHealth Group Incorporated Common Stock (DE)318,656$93.0M
GILDGILEAD SCIENCES, INC.513,306$77.1M
MRKMerck & Co., Inc.513,586$66.6M
MCKMcKesson Corporation65,582$61.2M
PFEPFIZER INC2,005,010$60.7M
CAHCardinal Health Inc.198,262$45.2M
AMGNAMGEN INC94,708$33.3M
BMYBRISTOL MYERS SQUIBB CO425,454$27.8M
BCRXBIOCRYST PHARMACEUTICALS INC2,505,726$25.7M
IDXXIDEXX LABORATORIES INC /DE41,738$25.3M
VRTXVERTEX PHARMACEUTICALS INC / MA52,378$25.2M
ZTSZoetis Inc.192,614$24.5M
REGNREGENERON PHARMACEUTICALS, INC.28,278$23.6M
CORCencora Inc.65,973$20.7M
ABTABBOTT LABORATORIES175,772$18.0M
ELANElanco Animal Health Inc682,888$17.6M
INDVIndivior Pharmaceuticals, Inc.535,060$17.6M
ALNYALNYLAM PHARMACEUTICALS, INC.46,954$16.7M
GMOptec International, Inc.194,552$15.6M
IQVIQVIA Holdings Inc.60,454$11.1M
ELVElevance Health Inc.29,278$8.6M
INSMINSMED Inc44,444$7.8M
GEHCGE HealthCare Technologies Inc.92,618$7.1M
RVMDREVOLUTION MEDICINES, INC.67,266$7.1M
BMRNBIOMARIN PHARMACEUTICAL INC112,120$6.8M
BIIBBIOGEN INC.30,526$6.0M
UTHRUNITED THERAPEUTICS Corp9,176$5.9M
NBIXNEUROCRINE BIOSCIENCES INC37,012$5.3M
MDXGMiMedx Group Inc1,218,224$5.2M
PTCTPTC THERAPEUTICS, INC.67,204$4.9M
KURAKura Oncology, Inc.541,614$4.7M
DGXQuest Diagnostics Incorporated22,400$4.7M
WSTWest Pharmaceutical Services Inc.14,918$4.0M
ZBHZimmer Biomet Holdings Inc.41,300$4.0M
RAREUltragenyx Pharmaceutical Inc.173,834$3.9M
MEDPMedpace Holdings Inc.7,436$3.8M
SHCSotera Health Company232,690$3.6M
INCYIncyte Corp.34,464$3.5M
ATAIAtai Beckley N.V.847,348$3.2M
NAGENiagen Bioscience, Inc.668,824$3.2M
OPKOPKO HEALTH, INC.2,204,508$2.7M
GHGuardant Health Inc.25,830$2.6M
VIRVir Biotechnology, Inc.226,056$2.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.21,684$1.5M
MYGNMYRIAD GENETICS INC297,858$1.4M
XNCRXencor Inc110,164$1.4M
SUPNSUPERNUS PHARMACEUTICALS, INC.16,326$910K
INSPInspire Medical Systems Inc.16,168$899K
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.4,680$870K
CORTCORCEPT THERAPEUTICS INC15,786$686K
RLAYRelay Therapeutics, Inc.58,434$627K
NKTRNEKTAR THERAPEUTICS7,982$619K
MIRMMirum Pharmaceuticals, Inc.6,102$608K
SRPTSarepta Therapeutics, Inc.19,992$469K
MNKDMANNKIND CORP172,964$457K
GMEDGlobus Medical Inc.2,978$277K
ALHCAlignment Healthcare Inc.14,386$273K
OSCROscar Health Inc.20,506$254K
MRNAModerna, Inc.4,592$251K
ACADACADIA PHARMACEUTICALS INC5,549$124K
LNTHLantheus Holdings, Inc.264$22K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    OP Asset Management Ltd — Biotech 13F Holdings & Portfolio | BioSniper